このアイテムのアクセス数: 219

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
j.ijpharm.2021.121185.pdf799.58 kBAdobe PDF見る/開く
タイトル: Impact of silicone oil tamponade on intravitreally injected vancomycin pharmacokinetics in cynomolgus monkey eyes
著者: Hira, Daiki  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0001-8344-2469 (unconfirmed)
Kitagawa, Tomoya
Imamura, Taku
Kakinoki, Masashi
Ueshima, Satoshi
Okano, Tomonobu
Ohji, Masahito
Kakumoto, Mikio
Terada, Tomohiro  kyouindb  KAKEN_id
著者名の別形: 平, 大樹
寺田, 智祐
キーワード: Silicone oil tamponade
Vancomycin
Population pharmacokinetics
Infectious endophthalmitis
Pars plana vitrectomy
Lensectomy
発行日: Nov-2021
出版者: Elsevier BV
誌名: International Journal of Pharmaceutics
巻: 609
論文番号: 121185
抄録: Intravitreal injections of vancomycin (VCM) and ceftazidime (CAZ) are commonly used to treat infectious endophthalmitis. When patient cases require retinal detachment with silicone oil (SO) tamponade, the antibiotic doses are empirically reduced to 25 %. Currently, there is no scientific evidence for these empirical dose reductions. The purpose of the present study is to determine the quantitative impact that SO tamponades have on intraocular VCM pharmacokinetics. Because of high invasiveness of frequent sampling of intraocular VCM concentrations in human, this pharmacokinetic study was performed in cynomolgus monkey’s eyes. Population pharmacokinetic modeling and simulation were performed using 75 different intraocular VCM concentrations obtained from 8 male cynomolgus monkeys. A one-compartment model with a first-order diffusion rate was used as a structural pharmacokinetic model. From the covariate analysis, SO tamponade significantly decreased the volume of distribution while pars plana vitrectomy with lensectomy (PPV) significantly increased the clearance and diffusion rate constants. From the Monte Carlo simulation (n = 1, 000), the median time above minimum inhibitory concentration (T>MIC, a therapeutic effect index) durations of SO and normal eyes at clinical doses of 1, 000 µg were 2.6 and 11.0 days, respectively. Using intravitreal injections of VCM with SO tamponade or PPV may reduce the therapeutic effect.
著作権等: © 2021. This manuscript version is made available under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International license.
The full-text file will be made open to the public on 20 November 2022 in accordance with publisher's 'Terms and Conditions for Self-Archiving'.
This is not the published version. Please cite only the published version. この論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。
URI: http://hdl.handle.net/2433/268984
DOI(出版社版): 10.1016/j.ijpharm.2021.121185
PubMed ID: 34655708
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons